Jubilant Ingrevia Ltd vs Tatva Chintan Pharma Chem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Jubilant Ingrevia Ltd is ₹ 584.7 as of 20 Mar 15:30 . The P/E Ratio of Jubilant Ingrevia Ltd changed from 76.6 on March 2021 to 40.9 on March 2025 . This represents a CAGR of -11.79% over 5 yearsThe P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 53.4 on March 2022 to 278.3 on March 2025 . This represents a CAGR of 51.09% over 4 years The Market Cap of Jubilant Ingrevia Ltd changed from ₹ 4158 crore on March 2021 to ₹ 10350 crore on March 2025 . This represents a CAGR of 20.01% over 5 yearsThe Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 5115 crore on March 2022 to ₹ 1588 crore on March 2025 . This represents a CAGR of -25.35% over 4 years The revenue of Jubilant Ingrevia Ltd for the Dec '25 is ₹ 1060 crore as compare to the Sep '25 revenue of ₹ 1131 crore. This represent the decline of -6.29% The revenue of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 133.07 crore as compare to the Sep '25 revenue of ₹ 124.52 crore. This represent the growth of 6.87% The ebitda of Jubilant Ingrevia Ltd for the Dec '25 is ₹ 122.91 crore as compare to the Sep '25 ebitda of ₹ 146.25 crore. This represent the decline of -15.96% The ebitda of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 27.22 crore as compare to the Sep '25 ebitda of ₹ 23.22 crore. This represent the growth of 17.23% The net profit of Jubilant Ingrevia Ltd changed from ₹ 48.74 crore to ₹ 46.9 crore over 7 quarters. This represents a CAGR of -2.17% The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 5.21 crore to ₹ 15.17 crore over 7 quarters. This represents a CAGR of 84.17% The Dividend Payout of Jubilant Ingrevia Ltd changed from 14.45 % on March 2021 to 30.24 % on March 2025 . This represents a CAGR of 15.92% over 5 yearsThe Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 708.79 % on March 2025 . This represents a CAGR of 105.04% over 5 years .

About Jubilant Ingrevia Ltd

Jubilant Ingrevia Limited (Formerly known as Jubilant LSI Limited) was incorporated as a Public Limited Company on October 23, 2019 in Uttar Pradesh.
The name of the Company was changed from 'Jubilant LSI Limited' to 'Jubilant Ingrevia Limited' on October 16, 2020. The Company is a global integrated Life Science products and Innovative Solutions provider serving Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards.
The Company is a part of the Jubilant Bhartia Group, a diversified global conglomerate founded by Mr. Shyam S. Bhartia and Mr. Hari S. Bhartia. Today, the Group has a strong presence in diverse sectors like Pharmaceuticals, Contract Research and Development Services, Proprietary Novel Drugs, Life Science Ingredients, Agri Products, Performance Polymers, Food Service (QSR), Food, Auto, Consulting in Aerospace and Oilfield Services.

About Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).

FAQs for the comparison of Jubilant Ingrevia Ltd and Tatva Chintan Pharma Chem Ltd

Which company has a larger market capitalization, Jubilant Ingrevia Ltd or Tatva Chintan Pharma Chem Ltd?

Market cap of Jubilant Ingrevia Ltd is 9,313 Cr while Market cap of Tatva Chintan Pharma Chem Ltd is 2,637 Cr

What are the key factors driving the stock performance of Jubilant Ingrevia Ltd and Tatva Chintan Pharma Chem Ltd?

The stock performance of Jubilant Ingrevia Ltd and Tatva Chintan Pharma Chem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jubilant Ingrevia Ltd and Tatva Chintan Pharma Chem Ltd?

As of March 23, 2026, the Jubilant Ingrevia Ltd stock price is INR ₹584.7. On the other hand, Tatva Chintan Pharma Chem Ltd stock price is INR ₹1127.45.

How do dividend payouts of Jubilant Ingrevia Ltd and Tatva Chintan Pharma Chem Ltd compare?

To compare the dividend payouts of Jubilant Ingrevia Ltd and Tatva Chintan Pharma Chem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.